共 45 条
[1]
Siegel R(2012)Cancer statistics, 2012 CA Cancer J Clin 62 10-29
[2]
Naishadham D(2000)Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938-2947
[3]
Jemal A(2000)Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group N Engl J Med 343 905-914
[4]
de Gramont A(2000)Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 1041-1047
[5]
Figer A(2009)Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer N Engl J Med 360 1408-1417
[6]
Seymour M(2004)Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335-2342
[7]
Saltz LB(2012)NICE guidance on cetuximab, bevacizumab, and panitumumab for treatment of metastatic colorectal cancer after first-line chemotherapy Lancet Oncol 13 233-234
[8]
Cox JV(2001)Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study J Clin Oncol 19 2282-2292
[9]
Blanke C(2012)Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen J Clin Oncol 30 3499-3506
[10]
Douillard JY(2004)Use of surgery among elderly patients with stage IV colorectal cancer J Clin Oncol 22 3475-3484